Clinical Trial Details
EORTC-08092
Back to Clinical Trials Database
Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 18-Jul-2011 Date Step1 close: 05-Aug-2013 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized blind |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT01208064 |
NCT number | NCT01208064 |
EudraCT | 2010-018566-23 |